Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P64
Within normal range
vs 2Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202514.84%
202432.28%
202324.10%
2022-11.66%
2021-18.62%
2020-25.33%
2019-18.11%
20189.93%
2017-46.87%
2016-54.84%